Development and validation procedures for the EXACT were consistent with guidelines for PRO instrument development proposed by the FDA and EMA and well-known measurement principles.

The process involved over 500 people, including 493 patients with COPD and 18 professionals from the US and Europe with expertise in pulmonary medicine, clinical research, instrument development, and drug development regulations.